Need Help? Contact Us

  Medical Specialties > Structural Heart > SENTINEL™ Cerebral Protection System

Firsthand observations from <br>Dr. Jochen Whörle.

Firsthand observations from
Prof. Jochen Whörle


Hear the impact of cerebral embolic protection described as observed in the largest propensity matched meta-analysis comparison of All-Stroke and mortality.

 
 

 

 

 

Seeing is believing

In 99% of procedures, SENTINEL was shown to capture and remove stroke-causing embolic debris.1

Results of using Sentinel
 
 

A growing body of evidence

SENTINEL leads the way in clinical evidence for cerebral embolic protection for over 2,600 patients across a randomized trial and multiple registries.

 

 
Rate reduction graph

1. SENTINEL IDE Trial. Data presented at SENTINEL FDA Advisory Panel, Feb 23, 2017.; 2. Van Mieghem N., TVT 2018 (includes TIA); 3. Stripe, B. PCR LV 2019; 4. Rinaldi, TCT 2018. 5. Chakravarty T., TCT 2018; 6. Seeger J., et al., JACC Cardiovasc Interv. 2017.

Fisher exact test; Results from different studies are not directly comparable. Information provided for educational purposes only.

 
 
Implementation

IMPLEMENTING CEP

Protected TAVR™ is a minimal investment proven to help keep patients safe

  Maximize Your Outcomes  
Implementation

Be Part of Our Vision

We take partnership to heart. Join our community to receive updates
and help us advance the treatment of structural heart valvular therapies.

Join Now

 

 

Instructions for Use  |  Ordering Information
Top